IP Library Granted Patent US 7,188,725
Granted Patent B2
US 7,188,725 · App. 11/237,374 · Granted Mar 13, 2007

Kits for preparing transition metal carbonyl complexes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,188,725
App. No.
11/237,374
Granted
Mar 13, 2007
Kind
B2
Abstract

The present invention relates to kits including compounds that may be used as a carbon monoxide source and optionally as a reducing agent in the preparation of transition metal carbonyl complexes.

Claims (68)

1. A kit for preparing a transition metal carbonyl complex, the kit comprising:

a buffer; and

a compound of the following formula

wherein:

X 1 , X 2 and X 3 are the same or different and are selected from either a Lewis base or hydride;

Y is a sigma donating group;

A is a cation selected from hydrogen and an alkali or alkaline earth metal;

n is 0, −1 or −2;

a is 0, +1 or +2; and

m is 0, +1 or +2.

2. A kit as in claim 1 wherein the compound is a boranocarbonate compound in which:

X 1 , X 2 and X 3 are —H; and

Y is —OH 2 , —OH, or —O − .

3. A kit as in claim 1 , wherein the compound is a borane amino acid in which:

X 1 is NH 3 ;

X 2 and X 3 are —H; and

Y is —OH or —O − .

4. A kit as in claim 1 , wherein the compound is an alkylated borane amino acid in which:

X 1 is —NH x R y with x+y=3, wherein R is alkyl or aryl which is bound by a carbon atom to the nitrogen;

X 2 and X 3 are —H; and

Y is —OH.

5. A kit as in claim 1 , wherein:

X 1 is an organic substituent bound by a carbon atom to boron;

X 2 and X 3 are —H; and

Y is —OH 2 .

6. A kit as in claim 1 , wherein:

Y is OR, R being an alkyl radical bound by a carbon atom to the oxygen.

7. A kit as in claim 1 , wherein:

X 1 , X 2 and X 3 are hydrogen; and

Y is NH 2 , NHR or NR 2 , wherein R is an alkyl radical selected from methyl and ethyl.

8. A kit as in claim 1 , wherein:

X 1 is an organic substituent bound by a carbon atom to boron;

X 2 and X 3 are —H; and

Z is —OH 2 .

9. A kit as in claim 1 , wherein:

X 1 and X 2 are organic substituents bound by a carbon atom to boron;

X 3 is —H; and

Z is —OH 2 .

10. A kit as in claim 1 , wherein the compound is selected from:

[H 3 B—COOH]H, [H 3 B—COOH]M, [H 3 B—COO]M 2 , Na[H 3 B—COOCH 3 ], Na[H 3 BCONHCH 3 ], M[H 3 B—CONH 2 ], [H 3 N—BH 2 —COOH], [H 3 N—BH 2 —COO]Li, [(CH 3 ) 3 N—BH 2 —COOH], [(CH 3 )H 2 N—BH 2 —COOH], [(CH 3 )H 2 N—BH 2 —COO]Li, [(CH 3 )H 2 N—BH 2 —COOCH 3 ], [H 3 N—BH 2 —CONH 2 ], and [(CH 3 ) 2 HN—BH 2 —CONHC 2 H 5 ], wherein M is an alkali metal cation.

11. A kit as in claim 1 , further comprising a reducing agent.

12. A kit as in claim 11 , wherein the reducing agent is selected from boron hydrides, dithionites, and SnCl 2 .

13. A kit as in claim 1 , further comprising a stabilizer.

14. A kit as in claim 13 , wherein the stabilizer is selected from glucoheptonate, tartrate, citrate, and lactate.

15. A kit as in claim 1 , wherein X 1 , X 2 and X 3 are substituents which are independently selected from —H, —R and —NH x R y , wherein x and y are integers and x+y=3, and wherein R is a substituent that is bound by a carbon atom to the boron or nitrogen, respectively.

16. A kit as in claim 15 , wherein Y is —OH, —OR or —NHR.

17. A kit as in claim 15 , wherein R is alkyl or aryl.

18. A kit as in claim 1 , wherein (a×m)+n=0.

19. A kit for preparing a transition metal carbonyl complex, the kit comprising:

a stabilizing agent; and

a compound of the following formula

wherein:

X 1 , X 2 and X 3 are substituents which are independently selected from —H, —R and —NH x R y , wherein x and y are integers and x+y=3, and wherein R is a substituent that is bound by a carbon atom to the boron or nitrogen, respectively;

Y is —OH, —OR′ or —NHR′, wherein R′ is alkyl or aryl;

A is a cation selected from hydrogen and an alkali or alkaline earth metal;

n is 0, −1 or −2;

a is 0, +1 or +2; and

m is 0, +1 or +2.

20. A kit for preparing a transition metal carbonyl complex, the kit comprising:

a buffer; and

a compound of the following formula

wherein:

X 1 , X 2 and X 3 are substituents which are independently selected from —H, —R and —NH x R y , wherein x and y are integers and x+y=3, and wherein R is a substituent that is bound by a carbon atom to the boron or nitrogen, respectively;

Y is —OH, —OR′ or —NHR′, wherein R′ is alkyl or aryl;

A is a cation selected from hydrogen and an alkali or alkaline earth metal;

n is 0, −1 or −2;

a is 0, +1 or +2; and

m is 0, +1 or +2.

Assignments (3)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED AT REEL/FRAME NO. 032480/0001 Recorded Jul 1, 2016
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT LLC
Reel/Frame 039237/0059 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →